Thanks Nasdaq for celebrating our recent $58M funding, as we advance our wearable biosensors for #metabolic health. 🚀🚀 Press release: 👉 https://lnkd.in/etnifyNB WSJ: 👉 https://lnkd.in/eCWamfgr Drug Delivery Business: 👉 https://lnkd.in/gt2gpYsc Medical Device Network: 👉 https://lnkd.in/eUg9j-_X Longevity Technology: 👉 https://lnkd.in/e_AUEke5 MassDevice: 👉 https://lnkd.in/gt2gpYsc
Biolinq
Medical Device
San Diego, California 8,093 followers
The Revolutionary Biosensing Platform for Metabolic Health.
About us
Biolinq has created a new Biowearable experience by using an array of electrochemical sensors so small you can barely feel them. Our metabolic health sensors work together to provide maximum reliability for continuous sensing applications. With the potential of multiple analytes such as glucose, ketones, and lactate, we provide an entirely new user experience with actionable metabolic health insights. Over the next 10 years we intend to bring Biosensing and Biowearables mainstream. We are dedicated to the personal and professional growth of all our team members and strive to create a positive and creative work environment.
- Website
-
http://biolinq.com
External link for Biolinq
- Industry
- Medical Device
- Company size
- 51-200 employees
- Headquarters
- San Diego, California
- Type
- Privately Held
Locations
-
Primary
10260 Sorrento Valley Rd
San Diego, California 92121, US
Employees at Biolinq
Updates
-
Thanks Marion W. at Medtech Insight for visiting our offices and speaking with our CEO Rich Yang. Biolinq’s CEO Rich Yang spoke to Medtech Insight about the company’s wearable patch in development, which uses tiny microsensors to measure, for now, glucose, with ample runway for additional indications down the line. If approved by the US FDA, the device would become the first of its kind to monitor glucose levels in diabetes patients not using insulin. https://lnkd.in/dsuTEmNv
-
Biolinq reposted this
Thanks to Biolinq's CEO Rich Yang for sitting down with Citeline, Medtech Insight about the firm's innovative technology, FDA plans, and DNA-aptamer tech, also in development. #diabetes #CGM #medtech #healthcare #FDA #wearables #patches #funding #glucosesensing #type1diabetes
Biolinq Aims To Transform Diabetic Glucose Monitoring With Needle-Free Patch
medtech.citeline.com
-
Watch the presentation at Fortune Brainstorm Tech 2024: 🚴🚴 https://lnkd.in/eJzzTAvC
Brainstorm Tech 2024: Biohacking Our Way to Better Health
fortune.com
-
Thanks to Olympic athlete Sky Christopherson for all your hard work today on stage at Fortune #BrainstormTech! 🚴🚴♂️🚴 Our CTO & Co-Founder Jared Tangney took real-time measurements of Sky on stage so the audience could see how exercise effects both glucose and lactate levels. Our CEO Rich Yang also did push-ups on stage today, and showed what the silicon microneedles look like with our wearable biosensor!
-
-
Thanks Fortune for having our CEO Rich Yang and Olympian Sky Christopherson present our wearable sensor technology today at the Fortune #BrainstormTech Conference. Our CTO & Co-Founder Jared Tangney was also on stage helping take real-time measurements! Really a team effort. What an incredible event and great meeting everyone there! 🎉🎉
-
-
We’re excited to share that our CEO Rich Yang and Olympic athlete Sky Christopherson will be on stage next week at the Fortune Brainstorm Tech Conference 2024! 🔥🔥🔥 Once again (now for 23 years), Fortune Brainstorm Tech brings together a community of Fortune 500 leaders with top investors, VCs, banking executives, startup founders, and global influencers. Sharing the list of speakers this year: https://lnkd.in/egWYBJAp More info about event: 👇👇 https://lnkd.in/e9nce9p9
-
-
Excited to announce that our CEO Rich Yang will be speaking at Fortune Brainstorm Tech next month! We will share more details closer to the event, July 15-17 in Park City, Utah. Once again (now for 23 years), Fortune Brainstorm Tech brings together a community of Fortune 500 leaders with top investors, VCs, banking executives, startup founders, and global influencers. The 2024 program will include insight and perspectives from a wide range of voices across the tech ecosystem. Learn more here: 👇👇 https://lnkd.in/e9nce9p9
FORTUNE BRAINSTORM TECH 2024
fortune.com
-
Thanks IEEE Spectrum for speaking with our CEO Rich Yang about our intradermal sensors. Medical technology company Biolinq is developing a new type of glucose sensor that doesn’t go deeper than the dermis, the middle layer of skin that sits above the subcutaneous tissue. The company’s “intradermal” biosensors take advantage of metabolic activity in shallower layers of skin, using an array of electrochemical microsensors to measure glucose—and other chemicals in the body—just beneath the skin’s surface. Read the article: 👇👇👇 https://lnkd.in/evMWz9dH
Microneedle Glucose Sensors Keep Monitoring Skin-Deep
spectrum.ieee.org
-
Honored to have our CEO Rich Yang recognized as a finalist in the EY Entrepreneur Of The Year® 2024 Pacific Southwest program. We cannot wait to cheer him on during the awards celebration on June 7 when winners will be announced! #EOYUS #EOYPACSW Meet all the finalists: https://lnkd.in/ez8YCksS More info: https://lnkd.in/gD6sJPBS